Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hemospray in Acute Variceal Bleeding
NCT03061604Completed
- Sponsor
- Theodor Bilharz Research Institute
- Start
- Nov 2014
- Primary completion
- Nov 2017
- Countries
- 2
01
Overview
Randomised, open-label trial (2 arms), sponsored by Theodor Bilharz Research Institute. Primary endpoint: Hemostasis (Endoscopic and Clinical) at 24 hours. Started Nov 2014; status: completed.
Beyond the preview
Go deeper on NCT03061604.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03061604.